Free Trial
NASDAQ:RDNT

RadNet (RDNT) Stock Price, News & Analysis

$61.98
+0.01 (+0.02%)
(As of 07/26/2024 ET)
Today's Range
$61.48
$63.55
50-Day Range
$56.22
$65.16
52-Week Range
$25.11
$66.04
Volume
573,104 shs
Average Volume
544,839 shs
Market Capitalization
$4.58 billion
P/E Ratio
206.60
Dividend Yield
N/A
Price Target
$64.00

RadNet MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
3.3% Upside
$64.00 Price Target
Short Interest
Bearish
4.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
1.20mentions of RadNet in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$6.12 M Sold Last Quarter
Proj. Earnings Growth
6.90%
From $0.58 to $0.62 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.23 out of 5 stars

Medical Sector

358th out of 936 stocks

Medical Laboratories Industry

11th out of 18 stocks

RDNT stock logo

About RadNet Stock (NASDAQ:RDNT)

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Stock Price History

RDNT Stock News Headlines

We recommended Nvidia in 2016, now we’re recommending this…
The AI boom is just getting started. And the real wealth has still to be made…
RadNet: Qualified Growth Route, Still Undervalued
We recommended Nvidia in 2016, now we’re recommending this…
The AI boom is just getting started. And the real wealth has still to be made…
Peeling Back The Layers: Exploring RadNet Through Analyst Insights
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:RDNT
Employees
10,288
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$64.00
High Stock Price Target
$75.00
Low Stock Price Target
$51.00
Potential Upside/Downside
+3.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$3.04 million
Pretax Margin
3.35%

Debt

Sales & Book Value

Annual Sales
$1.62 billion
Cash Flow
$3.25 per share
Book Value
$11.79 per share

Miscellaneous

Free Float
70,097,000
Market Cap
$4.58 billion
Optionable
Optionable
Beta
1.75

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Howard G. Berger M.D. (Age 78)
    Chairman, President & CEO
    Comp: $5.56M
  • Mr. Mark D. Stolper (Age 53)
    Executive VP & CFO
    Comp: $1.13M
  • Mr. Mital Patel (Age 38)
    Executive VP of Financial Planning & Analysis and Chief Administrative Officer
    Comp: $1.15M
  • Mr. Norman R. HamesMr. Norman R. Hames (Age 68)
    President & COO of Western Operations
    Comp: $1.28M
  • Mr. Stephen M. Forthuber (Age 63)
    President & COO of Eastern Operations
    Comp: $1.3M
  • Ms. Christine Nayoma Gordon (Age 60)
    Senior VP of Operations - Northern California & Director
    Comp: $384.38k
  • Mr. Ranjan Jayanathan (Age 68)
    Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Dr. A. Gregory Sorensen M.D. (Age 62)
    Executive VP, Chief Science Officer & Director
  • Ms. Laura Foster BSRT
    MPH, J.D., Senior Vice President of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz (Age 59)
    Executive VP, Chief Legal Officer & Corporate Secretary

RDNT Stock Analysis - Frequently Asked Questions

How have RDNT shares performed this year?

RadNet's stock was trading at $34.77 at the beginning of the year. Since then, RDNT stock has increased by 78.3% and is now trading at $61.98.
View the best growth stocks for 2024 here
.

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) posted its quarterly earnings data on Wednesday, May, 8th. The medical research company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.16. RadNet's revenue was up 10.5% compared to the same quarter last year.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are RadNet's major shareholders?

Top institutional shareholders of RadNet include Allspring Global Investments Holdings LLC (1.37%), Bank of New York Mellon Corp (0.78%), Harbor Capital Advisors Inc. (0.24%) and Calamos Advisors LLC (0.15%). Insiders that own company stock include Alma Gregory Sorensen, Norman R Hames, David L Swartz, Lawrence L Levitt, Mark Stolper, Michael N Murdock, David Jeffrey Katz, Ruth Louisa Villigerwilson, Christine Nayoma Gordon and Gregory E Spurlock.
View institutional ownership trends
.

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA) and Rigel Pharmaceuticals (RIGL).

This page (NASDAQ:RDNT) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners